Abstract

Karyotype alterations have emerged as on-target complications from CRISPR-Cas9 genome editing. However, the events that lead to these karyotypic changes in embryos after Cas9-treatment remain unknown. Here, using imaging and single-cell genome sequencing of 8-cell stage embryos, we track both spontaneous and Cas9-induced karyotype aberrations through the first three divisions of embryonic development. We observe the generation of abnormal structures of the nucleus that arise as a consequence of errors in mitosis, including micronuclei and chromosome bridges, and determine their contribution to common karyotype aberrations including whole chromosome loss that has been recently reported after editing in embryos. Together, these data demonstrate that Cas9-mediated germline genome editing can lead to unwanted on-target side effects, including major chromosome structural alterations that can be propagated over several divisions of embryonic development.

A possible undesired outcome of CRISPR-Cas9 germline editing is unwanted karyotype alterations. Here the authors track aberrations through three divisions of embryonic development following Cas9 editing.

Details

Title
Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing
Author
Papathanasiou Stamatis 1   VIAFID ORCID Logo  ; Markoulaki Styliani 2 ; Blaine, Logan J 1   VIAFID ORCID Logo  ; Leibowitz, Mitchell L 3   VIAFID ORCID Logo  ; Cheng-Zhong, Zhang 4   VIAFID ORCID Logo  ; Jaenisch Rudolf 5   VIAFID ORCID Logo  ; Pellman, David 3   VIAFID ORCID Logo 

 Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910) 
 Whitehead Institute, Cambridge, USA (GRID:grid.270301.7) (ISNI:0000 0001 2292 6283) 
 Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Howard Hughes Medical Institute, Chevy Chase, USA (GRID:grid.413575.1) (ISNI:0000 0001 2167 1581) 
 Department of Biomedical Informatics, Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Department of Data Sciences, Dana-Farber Cancer Institute, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910) 
 Whitehead Institute, Cambridge, USA (GRID:grid.270301.7) (ISNI:0000 0001 2292 6283); Massachusetts Institute of Technology, Department of Biology, Cambridge, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2579464590
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.